Subjects who received previous permanent implants in the nasolabial area at any time or who had any esthetic facial procedure performed in the nasolabial area within 6 months prior to enrollment that could interfere with the treatment outcome were excluded from the study. Also, patients with a history of autoimmune disorder or taking systemic corticosteroids were also excluded.